Abstract:OBJECTIVE:To separate the cell subpopulation with high tumorigenic ability and study the biological characteristics of this subpopulation in laryngeal carcinoma cells.METHODS:Human laryngeal carcinoma cells were obtained by primary tissue culture technique. CD44 and CD133 molecules were used as markers to isolate the CD44(+), CD133(+), CD44(+)CD133(+) and CD44(+)CD133(-) cell subpopulations from the laryngeal carcinoma cells by flow cytometry. A nude mouse tumor xenograft model was developed for the study of the tumorigenic effects of the different cell populations. 1 x 10(6), 1 x 10(5), 1 x 10(4) and 1 x 10(3) cells were injected into the left flank of the mice, respectively. The mice were observed for palpable tumor formation and were sacrificed at 4 weeks later to assess the tumor formation rate, tumor volume and tumor weight. Boyden chamber migration assay was used to determine the migration ability and immunochemistry was used to detect the expression of stem cell antigen SCA-1 and beta1-integrin. Semi-quantities RT-PCR and Western blot analysis were performed to detect the expression level of Bmi-1 in the different cell subpopulations.RESULTS:The growth of subcutaneous tumors in nude mice showed that a tumor can be generated with 1 x 10(3) CD44(+)CD133(+) cells. When the same dose of 1 x 10(6) CD44(+)CD133(+) cells was injected into the mice, both the average weight and volume of the tumors were significantly higher than those generated from other cell subpopulations. Boyden chamber migration assay showed that the invasion ability of CD44(+)CD133(+) cells was significantly higher than that of other cell subsets. The results of immunochemical analysis showed an abundant expression of stem cell antigen SCA-1 and beta1-integrin in the CD44(+)CD133(+) cells. Semi-quantitative RT-PCR and Western blot analysis provided strong evidence that the Bmi-1 expression in CD44(+)CD133(+) and CD133(+) cells was very significantly higher than that in CD44(+), CD44(+)CD133(-) and control cells (P < 0.01).CONCLUSION:Our findings demonstrate that CD44(+)CD133(+) subset cells in laryngeal carcinoma posses some biological characteristics of tumor stem cells, which may be the original cells of laryngeal carcinoma and may become a new target of tumor therapy.

In Vivo Investigation of Cd133 As A Putative Marker of Cancer Stem Cells in Hep-2 Cell Line

Identification and Characterization of CD133(pos) Subpopulation Cells from a Human Laryngeal Cancer Cell Line.

[Investigation of CD133 As Putative Marker of Tumor-Initiating Cell in Laryngeal Carcinoma].

[Isolation and in Vivo Tumorigenicity Assay of CD133+ Side Population Cells from Laryngeal Cancer Cell Line].

[Isolation and in Vitro Characterization of CD133(+) Side Population Cells from Laryngeal Cancer Cell Line].

Cooperation of Side Population Cells with CD133 to Enrich Cancer Stem Cells in a Laryngeal Cancer Cell Line

Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.

Cd133, One of the Markers of Cancer Stem Cells in Hep-2 Cell Line

Isolation and Characterization of Cancer Stem-Like Cells from MHCC97H Cell Lines

Chemoresistance of Cd133(+) Cancer Stem Cells in Laryngeal Carcinoma

Quantitative Analyses of CD133 Expression Facilitate Researches on Tumor Stem Cells.

The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.

Cd133 Is A Temporary Marker Of Cancer Stem Cells In Small Cell Lung Cancer, But Not In Non-Small Cell Lung Cancer

Clinicopathological Significance of Cancer Stem Cells Marked by CD133 and KAI1/CD82 Expression in Laryngeal Squamous Cell Carcinoma.

G Protein-Coupled Receptor 87 (Gpr87) Promotes The Growth And Metastasis Of Cd133(+) Cancer Stem-Like Cells In Hepatocellular Carcinoma

Identification and Characterization of Tumorigenic Liver Cancer Stem Cells by Cd133 and Cd24

Expression and Clinical Significance of the Stem Cell Marker Cd133 in Hepatocellular Carcinoma

A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells

[Biological Characteristics of Highly Tumorigenic CD44+CD133+ Subpopulation of Laryngeal Carcinoma Cells].

Cancer Stem/Progenitor Cells Are Highly Enriched In Cd133(+)Cd44(+) Population In Hepatocellular Carcinoma

Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells.